SEC Form D filing

UBIVAC, INC.

Biotech · Series A · Regulation D 506(b) · OR · Filed March 11, 2025

Offering amount: $4.5M
Exemption: Reg D 506(b)
Issuer state: OR
Filing date: March 11, 2025
Signature date: March 10, 2025
CIK: 0001713945

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: March 2025 Stage and month: Series A

Summary

Auto-generated

UBIVAC vaccine biotech with $4.45M offering in series-a range.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.